DJ AbbVie Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ slid 2.52% to $219.68 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.61% to 6,632.19 and Dow Jones Industrial Average falling 0.26% to 46,558.47.
This was the stock's second consecutive day of losses.
AbbVie Inc. closed 10.27% short of its 52-week high of $244.81, which the company reached on October 1st.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.21% to $241.52, Pfizer Inc. $(PFE)$ fell 1.04% to $26.58, and Amgen Inc. $(AMGN)$ fell 0.43% to $366.21.
Trading volume (5.7 M) remained 1.4 million below its 50-day average volume of 7.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 13, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 13, 2026 16:32 ET (20:32 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments